Feasibility and tolerability of transnasal/per-oral placement of the wireless pH capsule vs. traditional 24-h oesophageal pH monitoring - A randomized trial

Alimentary Pharmacology and Therapeutics

Volumn 21, Issue 2, 2005, Pages 155-163

  Wong, W M ^a   Bautista, J ^a   Dekel, R ^a   Malagon, I B ^a   Tuchinsky, I ^a   Green, C ^a   Dickman, R ^a   Esquivel, R ^a   Fass, R ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMBULATORY MONITORING; ARTICLE; CAPSULE ENDOSCOPE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DRUG ADMINISTRATION ROUTE; DRUG TOLERABILITY; EATING; ESOPHAGUS; ESOPHAGUS PH; FEASIBILITY STUDY; FEMALE; FOOD INTAKE; GASTROESOPHAGEAL REFLUX; HEADACHE; HUMAN; INTERMETHOD COMPARISON; MALE; NOSE; NOSE SECRETION; PAIN; PATIENT MONITORING; PATIENT SATISFACTION; PH MEASUREMENT; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; SLEEP; SORE THROAT; STATISTICAL SIGNIFICANCE; TELECOMMUNICATION; THORAX PAIN; WIRELESS PH CAPSULE;

CAPSULES; CIRCADIAN RHYTHM; ESOPHAGUS; FEASIBILITY STUDIES; FEMALE; GASTRIC ACID; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; MONITORING, AMBULATORY; SLEEP;

EID: 13544254482     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02313.x     Document Type: Article

References (13)

1. Dent J, Brun J, Fendrick AM, et al. An evidence-based appraisal of reflux disease management - the Genval Workshop Report. Gut 1999; 44(Suppl. 2): S1-S16.
2. Kahrilas PJ, Quigley EM. Clinical oesophageal pH recording: a technical review for practice guideline development. Gastroenterology 1996; 110: 1982-96.
3. DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastrooesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 1999; 94: 1434-42.
4. Richter JE. Extraoesophageal presentations of gastro-oesophageal reflux disease: an overview. Am J Gastroenterol 2000; 95(8 Suppl.): S1-3.
5. Pass R, Mackel C, Sampliner RE. 24-hour pH monitoring in symptomatic patients without erosive esophagitis who did not respond to antireflux treatment. J Clin Gastroenterol 1994; 19: 97-9.
6. Pass R. (ed.) Noncardiac chest pain. GERD/Dyspepsia, 1st edn. Philadelphia, PA: Hanley & Belfus, 2004: 183-96.
7. Pass R. Empirical trials in treatment of gastrooesophageal reflux disease. Dig Dis 2000; 18: 20-6.
8. Pass R, Hell R, Sampliner RE, et al. Effect of ambulatory 24-hour oesophageal pH monitoring on reflux-provoking activities. Dig Dis Sci 1999; 44: 2263-9.
9. Pandolfino JE, Richter JE, Ours T, Guardino JM, Chapman J, Kahrilas PJ. Ambulatory oesophageal pH monitoring using a wireless system. Am J Gastroenterol 2003; 98: 740-9.
10. Ward EM, Devault KR, Bouras EP, et al. Successful oesophageal pH monitoring with a catheter-free system. Aliment Pharmacol Ther 2004; 19: 449-54.
11. Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36): I. conceptual framework and item selection. Med Care 1992; 30: 473-83.
12. Velanovich V, Vallance SR, Gusz JR, Tapia FV, Harkabus MA. Quality of life scale for gastrooesophageal reflux disease. J Am Coll Surg 1996; 183: 217-24.
13. Kahrilas PJ, Lin S, Chen J, et al. The effect of hiatus hernia on gastro-oesophageal junction pressure. Gut 1999; 44: 476-82.